1 / 6

Cognitive Disorders Global Clinical Trials Review H2 2015

Cognitive Disorders Global Clinical Trials Review, H2, 2015 market research report is the latest addition to ReportsnReports.com and its collection of clinical trials business intelligence reports aimed to help take better decisions

anuragthakur2222
Download Presentation

Cognitive Disorders Global Clinical Trials Review H2 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cognitive Disorders Global Clinical Trials Review, H2, 2015 By ReportsnReports.com Publisher Name : GlobalData Date: Dec-2015 No. of pages: 1052 Single User License: US $2500 Browse more Reports on Clinical Trials at http://www.reportsnreports.com/tags/clinical-trials-market-research.html .

  2. Cognitive Disorders Global Clinical Trials Review, H2, 2015 GlobalData''s clinical trial report, “Cognitive Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Cognitive Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Cognitive Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

  3. Cognitive Disorders Global Clinical Trials Review, H2, 2015 Table of Contents: • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 • Top Five Countries Contributing to Clinical Trials in Europe • Top Countries Contributing to Clinical Trials in North America • Top Five Countries Contributing to Clinical Trials in Middle East and Africa • Top Five Countries Contributing to Clinical Trials in Central and South America • Clinical Trials by G7 Countries: Proportion of Cognitive Disorders to Central Nervous System Clinical Trials • Clinical Trials by Phase in G7 Countries • Clinical Trials in G7 Countries by Trial Status • Clinical Trials by E7 Countries: Proportion of Cognitive Disorders to Central Nervous System Clinical Trials • Clinical Trials by Phase in E7 Countries • Clinical Trials in E7 Countries by Trial Status • Clinical Trials by Phase • In Progress Trials by Phase • Clinical Trials by Trial Status • Clinical Trials by End Point Status • Subjects Recruited Over a Period of Time • Clinical Trials by Sponsor Type

  4. Cognitive Disorders Global Clinical Trials Review, H2, 2015 Scope For Cognitive Disorders Global Clinical Trials Review, H2, 2015 • The report provides a snapshot of the global clinical trials landscape • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment • The Report provides enrollment trends for the past five years • Report provides latest news for the past three months

  5. Cognitive Disorders Global Clinical Trials Review, H2, 2015 Reasons to Buy: • Assists in formulating key business strategies with regards to investment • Helps in identifying prominent locations for conducting clinical trials which saves time and cost • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities • Supports understanding of trials count and enrollment trends by country in global therapeutics market • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials • Facilitates clinical trial assessment of the indication on a global, regional and country level

  6. Cognitive Disorders Global Clinical Trials Review, H2, 2015 For more details contact Mr. Ritesh Tiwari :sales@reportsandreports.com/ +18883915441 ReportsnReports ReportsnReports.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. ReportsnReportsMarket Research library has syndicated reports by leading market research  publishers across the globe.

More Related